1. Challenges and regulatory context
First of all, we need to clarify the concept of a drug. According to the terms of the French Public Health Code, a drug can be :
"... any substance or composition presented as having curative or preventive properties with respect to human or animal diseases..."; case of a medicinal product by presentation;
"... any substance or composition which may be used in or administered to humans or animals, with a view to making a medical diagnosis or to restoring, correcting or modifying their physiological functions by exerting a pharmacological, immunological or metabolic action..."; case of a drug by function.
Thus, a product may be classified as a medicinal product on the basis of its qualitative and/or quantitative composition, or on the basis of the information affixed to its...
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Challenges and regulatory context
Analytical techniques
Article included in this offer
"Drugs and pharmaceuticals"
(
125 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
Bibliography
- (1) - - http://www.who.int/mediacentre/factsheets/ fs275/en/ (page consultée le 7 septembre 2016).
- (2) - -
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
